Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Aetna Inc    AET

AETNA INC (AET)
Mes dernières consult.
Most popular
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Aetna Ready For 'Dual Eligibles' Despite Commercial Focus - CFO

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/19/2012 | 09:55pm CEST
   By Jon Kamp 
   Of  
 

Aetna Inc. (>> Aetna Inc.) believes it can ably serve health-challenged patients covered by both Medicare and Medicaid, even though the company doesn't have a major stake in those markets.

Additionally, the commercially-focused health insurer doesn't need acquisitions to win business for "dual eligible" patients, according to Chief Financial Officer Joseph Zubretsky. Some of Aetna's big competitors have recently made deals with an eye on dual patients, and Aetna has faced questions about whether it has the right make-up for the market.

"I do believe we'll have the platforms built to be able to respond to this opportunity," Zubretsky said, speaking during an interview at Aetna's Hartford headquarters.

The market has significant potential, but will build over several years, giving Aetna time to grow its businesses from within, Zubretsky said. Meantime, Aetna has the capabilities within these businesses to address the kind of complex health problems dual patients often present, he said.

Dual patients, who represent a potential $300 billion market for health insurers, have become a hot topic as states and the federal government look for ways to better coordinate care and save money. These patients tend to rack up high costs due to their health challenges. A handful of states could have programs for covering dual patients up and running next year, and the market is expected to continue growing in subsequent years.

Managed-care companies could be big beneficiaries, but questions abound about which firms are best positioned to win state-by-state contracts. Analysts view Medicaid-focused insurers such as Molina Healthcare Inc. (>> Molina Healthcare, Inc.) and Centene Corp. (>> Centene Corp) as potential winners, and bigger insurers such as UnitedHealth Group Inc. (>> UnitedHealth Group Inc.) and WellPoint Inc. (WLP) are also expected to compete based on their presence in both the Medicaid and Medicare markets.

Aetna has modest stakes in markets for government-based plans. At the end of last year, roughly 90% of Aetna's 18.5 million medical members were on commercial health plan, which are typically plans provided through employers.

Citigroup analyst Carl McDonald recently said Aetna's valuation has been hurt by "the company's lack of government exposure". Still, Aetna shares are up 33% over the last year, helped by patients keeping a lid on health costs after the recession.

Competitors including UnitedHealth, WellPoint and Cigna Inc. (CI) have all recently made Medicare-focused acquisitions that could improve their chances in the duals market. Aetna has been wary of paying too much, however, and feels there is time to build up its own businesses.

"The opportunity has been reflected in certain managed care valuations long before the revenue is ever going to show up," Zubretsky said. "This is not a cataclysmic event where $300 billion dollars is going to race into the market inside of 12 months. It's going to happen in a phased approach."

Aetna Chief Executive Mark Bertolini has talked about the company's ability to grow its Medicare business by keeping commercial members on Aetna plans when they switch over to Medicare. There are about 1.2 million Medicare-eligible members in the company's commercial membership. He also noted Aetna has more than doubled revenue in its Medicaid business since acquiring it in 2007.

-By Jon Kamp, Dow Jones Newswires; 617-654-6728; [email protected]

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on AETNA INC
09/20 Pfizer files suit against J&J over Remicade contracts
09/20 AETNA : Allina-Aetna targeting large employer market in Minnesota
09/19 AETNA : Announces New Accountable Care Product in Tennessee Leveraging the Vande..
09/16 ANTHEM : insurance to stay in area ACA market
09/11 AETNA INC /PA/ : Regulation FD Disclosure (form 8-K)
09/08 AETNA : Offers Assistance to Members Affected by Hurricane Irma
09/06 AETNA : Executive to Present at CEO Investor Forum 2.0
09/04 AETNA : Texas Health Aetna adds to executive leadership team
09/01 AETNA : The Day, New London, Conn., David Collins column
08/31 AETNA : Signs Sponsorship Agreement with University of Virginia Athletics
More news
News from SeekingAlpha
07:30a GOP Senators to vote (again) to scuttle Obamacare
09/20 More support for Graham-Cassidy bill
09/19 Senate hearing on Graham-Cassidy bill
09/14 No leaving healthcare behind
08/22 Tracking Larry Robbins' Glenview Capital Management Portfolio - Q2 2017 Updat..
Financials ($)
Sales 2017 60 925 M
EBIT 2017 4 419 M
Net income 2017 1 950 M
Debt 2017 -
Yield 2017 0,99%
P/E ratio 2017 25,15
P/E ratio 2018 16,06
Capi. / Sales 2017 0,85x
Capi. / Sales 2018 0,80x
Capitalization 51 485 M
Chart AETNA INC
Duration : Period :
Aetna Inc Technical Analysis Chart | AET | US00817Y1082 | 4-Traders
Technical analysis trends AETNA INC
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 166 $
Spread / Average Target 7,2%
EPS Revisions
Managers
NameTitle
Mark T. Bertolini Chairman & Chief Executive Officer
Karen S. Lynch President
Margaret M. McCarthy Executive Vice President-Operations & Technology
Shawn M. Guertin CFO, Executive VP & Chief Enterprise Risk Officer
Harold L. Paz Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
AETNA INC25.83%51 485
UNITEDHEALTH GROUP23.83%189 263
ANTHEM INC29.78%48 182
CIGNA CORPORATION38.92%45 778
HUMANA INC22.18%34 638
CENTENE CORP69.85%15 654